| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | United States | IgE | 7 | 100.000 | 20130128, Posthumus J
| | 3.2.1 - Source Sensitized (IgE) | 1999 | Netherlands | IgE | 509 | 96.100 | | | 5.2.3 - Source Exposed, Children (Symptoms, SPT) | 2008 | Austria / Sweden | IgE | 68 | 95.590 | 20080512, Gronlund H
| | 5.2.2 - Source Exposed, Adults (Symptoms, SPT) | 2008 | Austria / Sweden | IgE | 72 | 94.440 | 20080512, Gronlund H
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 89.000 | 20140127, Konradsen JR
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2004 | Australia | IgE | 27 | 88.900 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 86.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Australia | IgE | 86 | 77.910 | 20140225, Hales BJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2011 | Zimbabwe | IgE | 31 | 74.190 | 20110307, Arkestal K
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 65.000 | 20091005, Ott H
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 59.450 | 20090826, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | Luxembourg | IgE | 35 | 51.430 | 20131227, Hilger C
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 48.480 | 20110223, De Knop KJ
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 42.900 | 20120310, Twaroch TE
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 42.300 | 20120310, Twaroch TE
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 40.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 35.710 | 20130111, Ott H
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 31.820 | 20091121, Ebo DG
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 30.300 | 20131020, van Rhijn BD
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 27.080 | 20120528, Patelis A
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 25.710 | 20130605, Simon D
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 20.930 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 20.060 | 20100301, Scala E
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2013 | United States | IgE | 45 | 20.000 | 20130409, Kennedy JL
| | 1.5 - Atopic Dermatitis, Diagnosed | 2005 | Germany | IgE | 113 | 19.500 | | | 1.4 - Respiratory Symptoms, Diagnosed | 2005 | Germany | IgE | 132 | 17.400 | | | 5.1.1 - Source Exposed (Symptoms) | 2005 | New Zealand | IgE | 199 | 13.100 | | | 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Iran, Islamic Republic of | IgE | 92 | 10.800 | 20140811, Teifoori F
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 8.000 | 20140821, Choi JS
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 4.850 | 20120528, Patelis A
| | 1.1 - Asymptomatic | 2011 | Zimbabwe | IgE | 47 | 0.000 | 20110307, Arkestal K
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
|
|
Loading...
Fel d 1
Homo sapiens
